60 Degrees Pharmaceuticals, Inc. SEC filings SXTPW
60 Degrees Pharmaceuticals, Inc. has 222 filings in SEC EDGAR's recent list, going back to Oct 18, 2022. Its latest annual report, Form 10-K, was filed on Mar 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 27, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| SCHEDULE 13G | Ownership over 5% (passive) | Aug 5, 2026 | — |
| 3 | Initial insider ownership | Jul 29, 2026 | Jul 22, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Jul 29, 2026 | — |
| 4 | Insider transaction | Jun 15, 2026 | Jun 12, 2026 |
| 3 | Initial insider ownership | May 19, 2026 | May 13, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 13, 2026 | — |
| 4 | Insider transaction | Dec 16, 2025 | Dec 15, 2025 |
| 4 | Insider transaction | Dec 12, 2025 | Dec 10, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 13, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 7, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 7, 2025 | — |
| 4 | Insider transaction | Sep 15, 2025 | Sep 12, 2025 |
| 4 | Insider transaction | Aug 14, 2025 | Sep 26, 2024 |
| 4 | Insider transaction | Aug 14, 2025 | Jan 17, 2025 |
| 3 | Initial insider ownership | Aug 14, 2025 | Feb 12, 2024 |
| SCHEDULE 13G | Ownership over 5% (passive) | Jul 22, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Jul 18, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jul 17, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Jul 17, 2025 | — |
| 4 | Insider transaction | Jun 9, 2025 | Jun 9, 2025 |
| 4 | Insider transaction | Jun 5, 2025 | Jun 3, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | May 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 14, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 11, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 3, 2025 | — |
| 4 | Insider transaction | Jan 24, 2025 | Jan 2, 2025 |
| 4 | Insider transaction | Jan 24, 2025 | Jan 2, 2025 |
| 4 | Insider transaction | Jan 21, 2025 | Jan 17, 2025 |
| 4 | Insider transaction | Jan 21, 2025 | Jan 17, 2025 |
| 4 | Insider transaction | Dec 18, 2024 | Dec 12, 2024 |
| 4 | Insider transaction | Dec 9, 2024 | Dec 5, 2024 |
| 4 | Insider transaction | Nov 21, 2024 | Nov 19, 2024 |
| SC 13G | Ownership over 5% (passive) | Nov 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 13, 2024 | — |
| 4 | Insider transaction | Sep 11, 2024 | Aug 27, 2024 |
| 4 | Insider transaction | May 21, 2024 | May 16, 2024 |
| 4 | Insider transaction | May 21, 2024 | Dec 31, 2023 |
| 4 | Insider transaction | May 21, 2024 | Nov 21, 2023 |
| 4 | Insider transaction | May 21, 2024 | Dec 31, 2023 |
| 4 | Insider transaction | May 21, 2024 | Nov 21, 2023 |
| 4 | Insider transaction | May 21, 2024 | Dec 31, 2023 |
| SC 13G/A | Amended ownership over 5% (passive) | May 7, 2024 | — |
| 4 | Insider transaction | Apr 3, 2024 | Jul 28, 2023 |
| 4 | Insider transaction | Feb 2, 2024 | Jan 31, 2024 |
| 4 | Insider transaction | Feb 2, 2024 | Jan 31, 2024 |
| SC 13G | Ownership over 5% (passive) | Dec 18, 2023 | — |
| 3 | Initial insider ownership | Dec 18, 2023 | Jul 11, 2023 |
| 4 | Insider transaction | Jul 12, 2023 | Jul 12, 2023 |
| 4 | Insider transaction | Jul 12, 2023 | Jul 12, 2023 |
| 3 | Initial insider ownership | Jul 11, 2023 | Jul 11, 2023 |
| 3 | Initial insider ownership | Jul 11, 2023 | Jul 11, 2023 |
| 3 | Initial insider ownership | Jul 11, 2023 | Jul 11, 2023 |
| 3 | Initial insider ownership | Jul 11, 2023 | Jul 11, 2023 |
| 3 | Initial insider ownership | Jul 11, 2023 | Jul 11, 2023 |
| 3 | Initial insider ownership | Jul 11, 2023 | Jul 11, 2023 |
| 3 | Initial insider ownership | Jul 11, 2023 | Jul 11, 2023 |
| 3 | Initial insider ownership | Jul 11, 2023 | Jul 11, 2023 |
| 3 | Initial insider ownership | Jul 11, 2023 | Jul 11, 2023 |
Showing 61 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- SXTP (Nasdaq), SXTPW (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Washington, DC
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1946563
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.